Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL

Carcinogenesis

Volumn 26, Issue 4, 2005, Pages 713-723

  Rashmi, Ramachandran ^a   Kumar, Santhosh ^a   Karunagaran, Devarajan ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; CURCUMIN; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL XL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CASPASE; COMPLEMENT; FLAVOPROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; PDCD8 PROTEIN, HUMAN; PROTEIN BCL 2; PROTEIN BCL X; SC5B 9 PROTEIN COMPLEX; SC5B-9 PROTEIN COMPLEX;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASES; COLONIC NEOPLASMS; COMPLEMENT SYSTEM PROTEINS; CURCUMIN; CYTOCHROMES C; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FLAVOPROTEINS; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 17844392101     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi025     Document Type: Article

References (51)

1. Martinou, J.C. and Green, D.R. (2001) Breaking the mitochondrial barrier. Nature Rev. Mol. Cell. Biol., 2, 63-67.
2. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86, 147-157.
3. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
4. Zou, H., Li, Y., Liu, X. and Wang, X. (1999) An APAF-1 · cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem., 274, 11549-11556.
5. Slee, E.A., Adrain, C. and Martin, S.J. (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ., 6, 1067-1074.
6. Du, C., Fang, M., Li, Y., Li, L. and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33-42.
7. Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., Simpson, R.J. and Vaux, D.L. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102, 43-53.
8. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K. and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell, 8, 613-621.
9. Hegde, R., Srinivasula, S.M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A.S., Fernandes-Alnemri, T. and Alnemri, E.S. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432-438.
10. Martins, L.M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N.F., Lemoine, N.R., Savopoulos, J., Gray, C.W., Creasy, C.L., Dingwall, C. and Downward, J. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem., 277, 439-444.
11. Verhagen, A.M., Silke, J., Ekert, P.G., Pakusch, M., Kaufmann, H., Connolly, L.M., Day, C.L., Tikoo, A., Burke, R., Wrobel, C., Moritz, R.L., Simpson, R.J. and Vaux, D.L. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem., 277, 445-454.
12. Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M. and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446.
13. Li, L.Y., Luo, X. and Wang, X. (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412, 95-99.
14. Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94, 491-501.
15. Korsmeyer, S.J., Wei, M.C., Saito, M., Weiler, S., Oh, K.J. and Schlesinger, P.H. (2000) Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ., 7, 1166-1173.
16. Chao, D.T. and Korsmeyer, S.J. (1998) BCL-2 family: regulators of cell death. Annu. Rev. Immunol., 16, 395-419.
17. Nechushtan, A., Smith, C.L., Lamensdorf, I., Yoon, S.H. and Youle, R.J. (2001) Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol., 153, 1265-1276.
18. Theodorakis, P., Lomonosova, E. and Chinnadurai, G. (2002) Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res., 62, 3373-3376.
19. Griffiths, G.J., Dubrez, L., Morgan, C.P., Jones, N.A., Whitehouse, J., Corfe, B.M., Dive, C. and Hickman, J.A. (1999) Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol., 144, 903-914.
20. Kandasamy, K., Srinivasula, S.M., Alnemri, E.S., Thompson, C.B., Korsmeyer, S.J., Bryant, J.L. and Srivastava, R.K. (2003) Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Cancer Res., 63, 1712-1721.
21. Hsu, Y.T. and Youle, R.J. (1998) Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem., 273, 10777-10783.
22. Makin, G.W., Corfe, B.M., Griffiths, G.J., Thistlethwaite, A., Hickman, J.A. and Dive, C. (2001) Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J., 20, 6306-6315.
23. Suzuki, M., Youle, R.J. and Tjandra, N. (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell, 103, 645-654.
24. Yamaguchi, H., Bhalla, K. and Wang, H.G. (2003) Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res., 63, 1483-1489.
25. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C. and Perucho, M. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967-969.
26. Zhang, L., Yu, J., Park, B.H., Kinzler, K.W. and Vogelstein, B. (2000) Role of BAX in the apoptotic response to anticancer agents. Science, 290, 989-992.
27. Kuo, M.L., Huang, T.S. and Lin, J.K. (1996) Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta, 1317, 95-100.
28. Piwocka, K., Zablocki, K., Wieckowski, M.R., Skierski, J., Feiga, I., Szopa, J., Drela, N., Wojtczak, L. and Sikora, E. (1999) A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res., 249, 299-307.
29. Chen, H., Zhang, Z.S., Zhang, Y.L. and Zhou, D.Y. (1999) Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res., 19, 3675-3680.
30. Rashmi, R., Santhosh Kumar, T.R. and Karunagaran, D. (2003) Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett., 538, 19-24.
31. Rashmi, R., Kumar, S. and Karunagaran, D. (2004) Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis, 25, 179-187.
32. Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, R.H. and Boyd, M.R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48, 589-601.
33. Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S. and Dixit, V.M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809.
34. Anto, R.J., Mukhopadhyay, A., Denning, K. and Aggarwal, B.B. (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-x1. Carcinogenesis, 23, 143-150.
35. Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J.C. and Perucho, M. (2000) Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl. Acad. Sci. USA, 97, 10872-10877.
36. Kitada, S., Krajewska, M., Zhang, X., Scudiero, D., Zapata, J.M., Wang, H.G., Shabaik, A., Tudor, G., Krajewski, S., Myers, T.G., Johnson, G.S., Sausville, E.A. and Reed, J.C. (1998) Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol., 152, 51-61.
37. Perucho, M. (1996) Cancer of the microsatellite mutator phenotype. Biol. Chem., 377, 675-684.
38. L. Cancer Res., 62, 1583-1587.
39. Yu, J., Tiwari, S., Steiner, P. and Zhang, L. (2003) Differential apoptotic response to the proteasome inhibitor bortezomib [VELCADE(TM), PS-341] in Bax-deficient and p21-deficient colon cancer cells. Cancer Biol. Ther., 2, 694-699.
40. Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B. and Korsmeyer, S.J. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-730.
41. Srinivasula, S.M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R.A., Robbins, P.D., Fernandes-Alnemri, T., Shi, Y. and Alnemri, E.S. (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/ DIABLO regulates caspase activity and apoptosis. Nature, 410, 112-116.
42. Marzo, I., Susin, S.A., Petit, P.X., Ravagnan, L., Brenner, C., Larochette, N., Zamzami, N. and Kroemer, G. (1998) Caspases disrupt mitochondrial membrane barrier function. FEBS Lett., 427, 198-202.
43. Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H.G. and Bhalla, K. (2002) Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/ DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood, 99, 3419-3426.
44. Fulda, S., Wick, W., Weller, M. and Debatin, K.M. (2002) Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nature Med., 8, 808-815.
45. McNeish, I.A., Bell, S., McKay, T., Tenev, T., Marani, M. and Lemoine, N.R. (2003) Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp. Cell Res., 286, 186-198.
46. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L. and Korsmeyer, S.J. (1996) BID: a novel BH3 domain-only death agonist. Genes Dev., 10, 2859-2869.
47. Rao, L., Modha, D. and White, E. (1997) The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene, 15, 1587-1597.
48. Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M., Thompson, C.B. and Korsmeyer, S.J. (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev., 14, 2060-2071.
49. Loeffler, M., Daugas, E., Susin, S.A., Zamzami, N., Metivier, D., Nieminen, A.L., Brothers, G., Penninger, J.M. and Kroemer, G. (2001) Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J., 15, 758-767.
50. Arnoult, D., Gaume, B., Karbowski, M., Sharpe, J.C., Cecconi, F. and Youle, R.J. (2003) Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J., 22, 4385-4399.
51. Arnoult, D., Karbowski, M. and Youle, R.J. (2003) Caspase inhibition prevents the mitochondrial release of apoptosis-inducing factor. Cell Death Differ., 10, 845-849.